Immunotherapy for metastatic colorectal cancer: Present status and new options.
Jan 2012 - :1502-7708 [PMID:22214467]
[Ellebaek E] [Andersen MH] [Svane IM] [Straten PT]

Immunotherapy of Lung Adenocarcinoma Patient with Peptide-Pulsed Dendritic Cells: a Case Report.
Dez 2011 - :1661-4917 [PMID:22143160]
[Wojas-Krawczyk K] [Krawczyk P] [Buczkowski J] [Walkowska A] [Jankowska O] [Czekajska-Chehab E] [Milanowski J]

A Novel Dendritic Cell-based Immunization Approach for the Induction of Durable Th1-polarized Anti-HER-2/neu Responses in Women With Early Breast Cancer.
Dez 2011 - :1537-4513 [PMID:22130160]
[Koski GK] [Koldovsky U] [Xu S] [Mick R] [Sharma A] [Fitzpatrick E] [Weinstein S] [Nisenbaum H] [Levine BL] [Fox K] [Zhang P] [Czerniecki BJ]

Development of sipuleucel-T: Autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer.
Nov 2011 - :1873-2518 [PMID:22122856]
[Sims RB]

Improved efficacy of therapeutic vaccination with dendritic cells pulsed with tumor cell lysate against hepatocellular carcinoma by introduction of 2 tandem repeats of microbial HSP70 peptide epitope 407-426 and OK-432.
Nov 2011 - Int. Immunopharmacol.; 11(12):1878-1705 [PMID:22015603]
[Ge C] [Xing Y] [Wang Q] [Xiao W] [Lu Y] [Hu X] [Gao Z] [Xu M] [Ma Y] [Cao R] [Liu J]

Long-term Vaccine Therapy with Autologous Whole Tumor Cell-pulsed Dendritic Cells for a Patient with Recurrent Rectal Carcinoma.
Nov 2011 - Anticancer Res.; 31(11):1791-7530 [PMID:22110233]
[Onishi H] [Morisaki T] [Baba E] [Nakamura M] [Inaba S] [Kuroki H] [Matsumoto K] [Katano M]

Pilot Clinical Trial of Type 1 Dendritic Cells Loaded with Autologous Tumor Lysates Combined with GM-CSF, Pegylated IFN, and Cyclophosphamide for Metastatic Cancer Patients.
Nov 2011 - J. Immunol.; 187(11):1550-6606 [PMID:22048768]
[Alfaro C] [Perez-Gracia JL] [Suarez N] [Rodriguez J] [Fernandez de Sanmamed M] [Sangro B] [Martin-Algarra S] [Calvo A] [Redrado M] [Agliano A] [Gonzalez A] [Rodriguez I] [Bolaños E] [Hervás-Stubbs S] [Perez-Calvo J] [Benito A] [Peñuelas I] [Vigil C] [Richter J] [Martinez-Forero I] [Melero I]

Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria.
Nov 2011 - :1432-0851 [PMID:22086161]
[Palma M] [Hansson L] [Choudhury A] [Näsman-Glaser B] [Eriksson I] [Adamson L] [Rossmann E] [Widén K] [Horváth R] [Kokhaei P] [Vertuani S] [Mellstedt H] [Osterborg A]

Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial.
Nov 2011 - J Transl Med; 9:1479-5876 [PMID:22013914]
[Baek S] [Kim CS] [Kim SB] [Kim YM] [Kwon SW] [Kim Y] [Kim H] [Lee H]

Immunotherapy for glioma: getting closer to the clinical arena?
Nov 2011 - Curr. Opin. Neurol.; 24(6):1473-6551 [PMID:22027543]
[Finocchiaro G] [Pellegatta S]

Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission.
Okt 2011 - :1432-0851 [PMID:22021066]
[Chu CS] [Boyer J] [Schullery DS] [Gimotty PA] [Gamerman V] [Bender J] [Levine BL] [Coukos G] [Rubin SC] [Morgan MA] [Vonderheide RH] [June CH]

Induction of tolerogenic dendritic cells by IL-6-secreting CT26 colon carcinoma.
Okt 2011 - :1532-2513 [PMID:21999714]
[Alshamsan A]

Current Vaccination Strategies for Prostate Cancer.
Okt 2011 - :1873-7560 [PMID:22001436]
[Joniau S] [Abrahamsson PA] [Bellmunt J] [Figdor C] [Hamdy F] [Verhagen P] [Vogelzang NJ] [Wirth M] [Van Poppel H] [Osanto S]

[Prostate carcinoma : Vaccination as a new option for treatment.]
Okt 2011 - :1433-0563 [PMID:21989588]
[Bedke J] [Gouttefangeas C] [Stenzl A]

Dendritic cell-based vaccines positively impact natural killer and regulatory T cells in hepatocellular carcinoma patients.
Okt 2011 - Clin. Dev. Immunol.; 2011:1740-2530 [PMID:21969837]
[Bray SM] [Vujanovic L] [Butterfield LH]